Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Giannina Gaslini Institute

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Giannina Gaslini Institute (Istituto Giannina Gaslini) is Italy's leading pediatric hospital, research center, and university teaching hub. Founded in 1938 by industrialist Gerolamo Gaslini in memory of his daughter Giannina, the institution is officially designated as a Scientific Institute for Research, Hospitalization, and Healthcare (IRCCS). The hospital is highly specialized, providing a full spectrum of complex medical and surgical care for mothers, newborns, children, and adolescents, while operating in close partnership with the University of Genoa to drive cutting-edge translational research and advanced pediatric training.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Children's hospital

Business Subcategory

Source: Human-provided. Children's hospital
Source: Human-provided. Child health care center
Source: Trial-derived.
64Total Trials
Source: Trial-derived.
22Recruiting Trials
Source: Trial-derived.
42Active Trials
Source: Trial-derived.
16Completed Trials
Source: Trial-derived.
104Unique Conditions
Source: Trial-derived.
101Unique Sponsors

Conditions

Source: Trial-derived. Dravet Syndrome (4)Source: Trial-derived. Muscular Atrophy, Spinal (3)Source: Trial-derived. Developmental and Epileptic Encephalopathy (2)Source: Trial-derived. Heart Failure (Pediatric) (2)Source: Trial-derived. Juvenile Idiopathic Arthritis (2)Source: Trial-derived. Left Ventricular Systolic Dysfunction (2)Source: Trial-derived. Neuroblastoma (2)Source: Trial-derived. Retinopathy of Prematurity (ROP) (2)

Sponsors

Source: Trial-derived. Istituto Giannina Gaslini (9)Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. European Society for Blood and Marrow Transplantation (3)Source: Trial-derived. F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore (3)Source: Trial-derived. Longboard Pharmaceuticals (3)Source: Trial-derived. Pfizer (3)Source: Trial-derived. Bayer (2)Source: Trial-derived. Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (2)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Echocardiography
Source: AI-inferred. Spirometry
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT
Source: AI-inferred. Six-minute walk test

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Specimen packaging and shipment

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic participant diary platform
Source: AI-inferred. Anti-AAVrh74 antibody titer testing
Source: AI-inferred. Bayley Scales of Infant and Toddler Development assessment
Source: AI-inferred. Cycloplegic refraction by retinoscopy
Source: AI-inferred. Electronic participant seizure diary (ePRO) system
Source: AI-inferred. Electronic participant/caregiver diary (eDiary)
Source: AI-inferred. Electronic patient/caregiver diary (ePRO) system
Source: AI-inferred. Intrathecal drug administration